RRML - Implications of visfatin genetic variants in the metabolic profile of the Romanian pediatric population

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Advanced search

Top 10 downloaded articles
- February 2024 -
Anti-thyroid peroxidase (TPO) ... 18
Romanian Review of Laboratory ... 17
Recomandarea comună EFLM-COLA... 13
Approaching Risk Management in... 12
Identification of shared hub g... 12
Challenges in prophylactic the... 12
Monocyte to high-density lipop... 9
Atellica CH 930 chemistry anal... 8
Setting up an own laboratory p... 7
Understanding the key differen... 7

Log in

Concept, Design & Programming
Dr. Adrian Man

Nr. 28(2)/2020 DOI:10.2478/rrlm-2020-0015

Research article

Implications of visfatin genetic variants in the metabolic profile of the Romanian pediatric population

Simona Loredana Vasilache, Cristina Oana Mărginean, Anastasia Boaghi, Raluca-Monica Pop, Claudia Banescu, Valeriu G Moldovan, Adina Hutanu, Carmen Duicu, Ionela Maria Pascanu

Correspondence should be addressed to: Claudia Banescu


Background: Conflictual results regarding the relationship between plasmatic level of visfatin and obesity could be explained by the influence of the gene variants involved in the synthesis or action of these hormones. Objectives: The present study examined the potential implication of single nucleotide polymorphisms (SNPs) of nicotinamide phosphoribosyltransferase (NAMPT) gene that encodes visfatin, in obesity, in a Romanian pediatric population. Method: A case-control study was conducted on a group of 213 children, divided into two: the case group - 130 overweight and obese children with BMI >1 SD, and the control group - 83 children with normal BMI. The variables analyzed were age, sex, anthropometric parameters, body composition based on bioimpedance analysis, lipid profile, visfatin and insulin plasmatic levels, rs4730153 and rs2302559 visfatin SNPs. Results: Significant associations were not found between rs4730153 and rs2302559 visfatin SNPs and obesity. Regarding lipid metabolism, there are statistically significant differences between triglyceride levels according to NAMPT rs2302559 genotypes (p=0.045), with heterozygous genotype having the highest level of triglycerides, and also between cholesterol levels according to NAMPT rs4730153 genotypes (p=0.030), with carriers of heterozygote genotype having the highest level of cholesterol. There is a statistically significant difference between the studied parameters in the investigated groups, regarding cholesterol, in carrier of wild-type genotype of NAMPT rs2302559 (p=0.040) and carrier of wild-type genotype of NAMPT rs4730153 (p=0.036). We observed no association of NAMPT rs4730153 and rs2302559 with visfatin levels in the studied groups. Visfatin level was lower in the case group and was correlated with weight (p=0.042), abdominal circumference (p=0.010), waist to height ratio (p=0.040), but not with the elements of the metabolic profile. Conclusion: NAMPT rs2302559 and rs4730153 polymorphisms do not seem to have a major impact in the development of obesity in children, however there may be an association with lipid profile, but further studies are needed.

Keywords: visfatin, insulin, visfatin polymorphisms, pediatric obesity

Received: 7.9.2019
Accepted: 3.2.2020
Published: 7.2.2020

  PDF Download full text PDF
(409 KB)
How to cite
Vasilache SL, Mărginean CO, Boaghi A, Pop RM, Banescu C, Moldovan VG, et al. Implications of visfatin genetic variants in the metabolic profile of the Romanian pediatric population. Rev Romana Med Lab. 2020;28(2):163-74. DOI:10.2478/rrlm-2020-0015